1. Home
  2. VRDN vs NTB Comparison

VRDN vs NTB Comparison

Compare VRDN & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • NTB
  • Stock Information
  • Founded
  • VRDN 2006
  • NTB 1858
  • Country
  • VRDN United States
  • NTB Bermuda
  • Employees
  • VRDN N/A
  • NTB N/A
  • Industry
  • VRDN Medical Specialities
  • NTB Commercial Banks
  • Sector
  • VRDN Health Care
  • NTB Finance
  • Exchange
  • VRDN Nasdaq
  • NTB Nasdaq
  • Market Cap
  • VRDN 1.6B
  • NTB 1.8B
  • IPO Year
  • VRDN N/A
  • NTB 2016
  • Fundamental
  • Price
  • VRDN $23.63
  • NTB $46.26
  • Analyst Decision
  • VRDN Strong Buy
  • NTB Hold
  • Analyst Count
  • VRDN 10
  • NTB 3
  • Target Price
  • VRDN $36.78
  • NTB $50.67
  • AVG Volume (30 Days)
  • VRDN 1.5M
  • NTB 247.5K
  • Earning Date
  • VRDN 11-13-2025
  • NTB 10-28-2025
  • Dividend Yield
  • VRDN N/A
  • NTB 4.32%
  • EPS Growth
  • VRDN N/A
  • NTB 17.07
  • EPS
  • VRDN N/A
  • NTB 5.27
  • Revenue
  • VRDN $305,000.00
  • NTB $599,452,000.00
  • Revenue This Year
  • VRDN N/A
  • NTB $3.17
  • Revenue Next Year
  • VRDN $34,044.63
  • NTB N/A
  • P/E Ratio
  • VRDN N/A
  • NTB $8.78
  • Revenue Growth
  • VRDN 5.90
  • NTB 4.60
  • 52 Week Low
  • VRDN $9.90
  • NTB $34.77
  • 52 Week High
  • VRDN $27.20
  • NTB $46.89
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 62.01
  • NTB 70.13
  • Support Level
  • VRDN $21.65
  • NTB $41.71
  • Resistance Level
  • VRDN $24.23
  • NTB $42.45
  • Average True Range (ATR)
  • VRDN 1.11
  • NTB 0.98
  • MACD
  • VRDN -0.03
  • NTB 0.54
  • Stochastic Oscillator
  • VRDN 68.07
  • NTB 91.01

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About NTB Bank of N.T. Butterfield & Son Limited (The) Voting

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.

Share on Social Networks: